发明授权
- 专利标题: Aromatic-ring-fused pyrimidine derivative
- 专利标题(中): 芳香环稠合嘧啶衍生物
-
申请号: US11576889申请日: 2005-10-05
-
公开(公告)号: US07557112B2公开(公告)日: 2009-07-07
- 发明人: Yasuhiro Yonetoku , Kenji Negoro , Kenichi Onda , Masahiko Hayakawa , Daisuke Sasuga , Takahiro Nigawara , Kazuhiko Iikubo , Hiroyuki Moritomo , Shigeru Yoshida , Takahide Ohishi
- 申请人: Yasuhiro Yonetoku , Kenji Negoro , Kenichi Onda , Masahiko Hayakawa , Daisuke Sasuga , Takahiro Nigawara , Kazuhiko Iikubo , Hiroyuki Moritomo , Shigeru Yoshida , Takahide Ohishi
- 申请人地址: JP Tokyo
- 专利权人: Astellas Pharma Inc.
- 当前专利权人: Astellas Pharma Inc.
- 当前专利权人地址: JP Tokyo
- 代理机构: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
- 优先权: JP2004-295559 20041008
- 国际申请: PCT/JP2005/018412 WO 20051005
- 国际公布: WO2006/040966 WO 20060420
- 主分类号: A61P3/10
- IPC分类号: A61P3/10 ; C07D495/04 ; C07D279/12 ; C07D417/04 ; C07D413/04 ; A61K31/541 ; A61K31/5355 ; A61K31/519
摘要:
There are provided novel pyrimidine derivatives which has been fused with an aromatic heterocycle selected from thiophene, thiazole and pyridine or pharmaceutically acceptable salts thereof; and a pharmaceutical composition comprising said compound as an active ingredient. These compounds exhibit excellent promoting activity on insulin secretion and activity against hyperglycemia. Hence, the pharmaceutical compositions comprising such compounds as active ingredients, based on these actions, are useful for treating and/or preventing insulin-dependent diabetes (type 1 diabetes), non-insulin-dependent diabetes (type 2 diabetes), insulin-resistant diseases, obesity, and the like.
公开/授权文献
- US20070249587A1 Aromatic-Ring-Fused Pyrimidine Derivative 公开/授权日:2007-10-25
信息查询